Corsi Christopher MD is categorized under Internal Medicine Doctors in Missoula, MT and active since 2011.
Corsi Christopher MD was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Christopher Corsi at the company’s single location by writing to 500 West Broadway St, Missoula, Montana MT 59802 or by phoning (406) 721-5600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Corsi Christopher MD |
Contact Person: | Christopher Corsi |
Address: | 500 West Broadway St, Missoula, Montana 59802 |
Phone Number: | (406) 721-5600 |
Website Address: | westernmontanaclinic.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Corsi Christopher MD was started in 2011 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Christopher Corsi for inquiries that concern Corsi Christopher MD by calling the company number (406) 721-5600, as your correspondence is most welcome. Additionally, the physical location of the single location of Corsi Christopher MD can be found at the coordinates 46.870207,-113.9876 as well as the street address 500 West Broadway St in Missoula, Montana 59802.
For its online presence, you may visit Corsi Christopher MD’s website at westernmontanaclinic.com and engage with its social media outlets through on Twitter and on Facebook.